CBIS News and Events

News & Events

Deep Learning Enables Dual Screening for Cancer and Cardiovascular Disease

Heart disease and cancer are the leading causes of death in the United States, and it’s increasingly understood that they share common risk factors, including tobacco use, diet, blood pressure, and obesity. Thus, a diagnostic tool that could screen for cardiovascular disease while a patient is already being screened for cancer has the potential to expedite a diagnosis, accelerate treatment, and improve patient outcomes. 

Hepatitis C Drugs Multiply Effect of COVID-19 Antiviral Remdesivir

When combined with drugs currently used to treat hepatitis C, the antiviral remdesivir is 10 times more effective in treating cells infected with SARS-CoV-2, the virus that causes COVID-19.

Self-Built Protein Coatings Could Improve Biomedical Devices

Fouling is a natural phenomenon that describes the tendency of proteins in water to adhere to nearby surfaces. It’s what causes unwanted deposits of protein to form during some food production or on biomedical implants, causing them to fail. Researchers at Rensselaer Polytechnic Institute are harnessing this process, which is typically considered a persistent challenge, to develop a versatile and accessible approach for modifying solid surfaces.

Polymerized Estrogen Provides Neuroprotection in Preclinical Testing

A novel form of polymerized estrogen developed at Rensselaer Polytechnic Institute can provide neuroprotection when implanted at the site of a spinal cord injury — preventing further damage. This promising result, found in a preclinical model, was recently published in ACS Chemical Neuroscience, and it lays the groundwork for further advancement of this new biomaterial.  

Time Needed To Sequence Key Molecules Could Be Reduced From Years to Minutes

Using a nanopore, researchers have demonstrated the potential to reduce the time required for sequencing a glycosaminoglycan — a class of long chain-linked sugar molecules as important to our biology as DNA — from years to minutes.

Common Bacteria Modified To Make Designer Sugar-Based Drug

Envisioning an animal-free drug supply, scientists have — for the first time — reprogrammed a common bacterium to make a designer polysaccharide molecule used in pharmaceuticals and nutraceuticals. 

In Era of Online Learning, New Testing Method Aims To Reduce Cheating

The era of widespread remote learning brought about by the COVID-19 pandemic requires online testing methods that effectively prevent cheating, especially in the form of collusion among students. With concerns about cheating on the rise across the country, a solution that also maintains student privacy is particularly valuable.

Green Tea Compound Aids p53, “Guardian of the Genome” and Tumor Suppressor

An antioxidant found in green tea may increase levels of p53, a natural anti-cancer protein, known as the “guardian of the genome” for its ability to repair DNA damage or destroy cancerous cells.

Green Tea Compound Aids Tumor-Suppressing, DNA-Repairing Protein

An antioxidant found in green tea may increase levels of p53, a natural anti-cancer protein, known as the “guardian of the genome” for its ability to repair DNA damage or destroy cancerous cells.

Jonathan Dordick Elected to National Academy of Engineering

TROY, N.Y. — Jonathan Dordick, the Howard P. Isermann ’42 Professor of Chemical and Biological Engineering at Rensselaer Polytechnic Institute, has been elected to the National Academy of Engineering (NAE), for his “contributions to methods for rapidly screening drug efficacy and toxicity, and biocatalytic technologies for improving human health.”

New NIH Grant Supports Single Molecule Study of Protein Key to Alzheimer’s Disease

A new grant from the National Institute On Aging at the National Institutes of Health will support ongoing research at Rensselaer Polytechnic Institute to address Alzheimer’s disease caused by gene mutations. According to Chunyu Wang, the principal investigator and an assistant professor of biological sciences at Rensselaer, the project seeks to understand and counter the mechanism that produces Amyloid-Beta 42 peptide in brain cells.

Pages